Physician profile
Salem Samra
NPI 1609050939
$15,162.19
in general payments reported to CMS, 2019-2025
20 companies · $3,248 in 2025
The $3,248 reported for 2025 was more than what 90% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $832 · 2020: $577 · 2021: $350 · 2022: $607 · 2023: $454 · 2024: $9,095 · 2025: $3,248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,589 · Food and Beverage: $3,026 · Long Term Medical Supply Or Device Loan: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,589.44 |
| Food and Beverage | $3,026.06 |
| Long Term Medical Supply Or Device Loan | $181.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $8,865.57 | 2019-2025 | Pico, Renasys Touch, Grafix Pl |
| Abbvie INC. | $2,390.06 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm |
| Musculoskeletal Transplant Foundation INC. | $905.26 | 2019-2025 | |
| Axogen | $494.49 | 2019-2021 | |
| Motiva USA, LLC | $430.79 | 2025 | |
| Allergan, INC. | $393.99 | 2019-2022 | |
| Integra Lifesciences Corporation | $389.61 | 2019-2025 | Integra, Omnigraft, Surgimend |
| Mentor Worldwide LLC | $277.44 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Sientra, INC. | $263.05 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $216.66 | 2019-2022 | |
| Medtronic, INC. | $117.20 | 2022 | |
| Intuitive Surgical, INC. | $100.33 | 2023 | |
| Merz North America, INC. | $98.58 | 2023 | |
| Revance Therapeutics, INC. | $55.20 | 2025 | Daxxify |
| Polynovo North America LLC | $49.18 | 2025 | Novosorb Btm |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $34.13 | 2024-2025 | Exparel, Iovera |
| Convatec INC. | $24.09 | 2024 | |
| Becton, Dickinson and Company | $23.44 | 2022 | |
| Endo USA, INC. | $16.69 | 2025 | Xiaflex |
| Davol INC. | $16.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salem Samra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.